NCT03931902

Brief Summary

Objectives: To compare the perioperative respiratory adverse events between using laryngeal mask airway and endotracheal tube in preterm neonates receiving general anesthesia for hernia surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 30, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

September 12, 2019

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 25, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2021

Completed
Last Updated

March 15, 2022

Status Verified

December 1, 2020

Enrollment Period

1.7 years

First QC Date

April 23, 2019

Last Update Submit

March 13, 2022

Conditions

Keywords

pediatric airway management

Outcome Measures

Primary Outcomes (2)

  • Perioperative respiratory complication

    laryngospasm, bronchospasm, severe cough, delayed extubation or prolonged oxygen dependence, apnea, bradycardia, and postoperative stridor

    from induction of anesthesia to postoperative 24 hours

  • postoperative hospital stays

    the lengths of postoperative hospital stays

    from postoperative day 1 up to postoperative day 30

Study Arms (2)

Laryngeal Mask Airway (LMA)

EXPERIMENTAL

Using laryngeal mask airway as the airway device during general anesthesia

Device: intubation with laryngeal mask airway

Endotracheal Tube (ETT)

ACTIVE COMPARATOR

Using endotracheal tube as the airway device during general anesthesia

Device: intubation with Endotracheal tube

Interventions

After masking ventilation with sevoflurane till the adequate anesthetic depth, intubation will be done with endotracheal tube (ETT).

Endotracheal Tube (ETT)

After masking ventilation with sevoflurane till the adequate anesthetic depth, intubation will be done with laryngeal mask airway (LMA).

Laryngeal Mask Airway (LMA)

Eligibility Criteria

AgeUp to 52 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • preterm neonates (gestational age \< 37 weeks) in our neonatal ward scheduled to receive unilateral or bilateral inguinal hernia repair surgery, and whose body weight \> 2000g at surgery

You may not qualify if:

  • emergent surgery, infants who was intubated before surgery, long-term oxygen or mechanical ventilation dependence, severe congenital cardiopulmonary disease, lacking of birth history, combination with other major surgery, postmenstrual age \> 52 weeks at surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kaohsiung Medical University Hospital

Kaohsiung City, 813, Taiwan

Location

MeSH Terms

Conditions

Premature Birth

Interventions

IntubationLaryngeal Masks

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsInvestigative TechniquesIntubation, IntratrachealAirway ManagementMasksProtective DevicesEquipment and SuppliesPersonal Protective EquipmentManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Miaopei Su, Master

    Kaohsiung Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 23, 2019

First Posted

April 30, 2019

Study Start

September 12, 2019

Primary Completion

May 25, 2021

Study Completion

May 25, 2021

Last Updated

March 15, 2022

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations